Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.bios.2010.07.054
Title: Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients
Authors: Tan, S.J.
Lakshmi, R.L.
Chen, P.
Lim, W.-T.
Yobas, L.
Lim, C.T. 
Keywords: Cancer cell isolation
Cell mechanical properties
Circulating tumor cells (CTCs)
Microfluidics
Physical separation
Issue Date: 15-Dec-2010
Source: Tan, S.J., Lakshmi, R.L., Chen, P., Lim, W.-T., Yobas, L., Lim, C.T. (2010-12-15). Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients. Biosensors and Bioelectronics 26 (4) : 1701-1705. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bios.2010.07.054
Abstract: The isolation of circulating tumor cells (CTCs) using microfluidics is attractive as the flow conditions can be accurately manipulated to achieve an efficient separation. CTCs are rare events within the peripheral blood of metastatic cancer patients which makes them hard to detect. The presence of CTCs is likely to indicate the severity of the disease and increasing evidences show its use for prognostic and treatment monitoring purposes. We demonstrated an effective separation using a microfluidic device to utilize the unique differences in size and deformability of cancer cells to blood cells. Using physical structures placed in the path of blood specimens in a microchannel, CTCs which are generally larger and stiffer are retained while most blood constituents are removed. The placements of the structures are optimized by computational analysis to enhance the isolation efficiency. With blood specimens from metastatic lung cancer patients, we confirmed the successful detection of CTCs. The operations for processing blood are straightforward and permit multiplexing of the microdevices to concurrently work with different samples. The microfluidic device is optically transparent which makes it simple to be integrated to existing laboratory microscopes and immunofluorescence staining can be done in situ to distinguish cancer cells from hematopoietic cells. This also minimizes the use of expensive staining reagents, given the small size of the microdevice. Identification of CTCs will aid in the detection of malignancy and disease stage as well as understanding the phenotypic and genotypic expressions of cancer cells. © 2010 Elsevier B.V.
Source Title: Biosensors and Bioelectronics
URI: http://scholarbank.nus.edu.sg/handle/10635/61665
ISSN: 09565663
DOI: 10.1016/j.bios.2010.07.054
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

113
checked on Dec 13, 2017

WEB OF SCIENCETM
Citations

101
checked on Nov 16, 2017

Page view(s)

28
checked on Dec 10, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.